4d Pharma Plc

4d Pharma (DDDD)

Company name:4d Pharma Plc
EPIC:DDDDTrading Currency:GBX
Market Sector:ASM7ISIN:GB00BJL5BR07
Market Segment:AMSMShare Type:DE
WWW Address:http://www.4dpharmaplc.com/Description:ORD 0.25P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 110.00 images.advfn.com/imagesnew/2/gb/up 0.5 [0.46] 109.00 111.00 - - - 194,154
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 72.04 65.49 -0.83 -36.17 - - - 147.50 - 65.00

4d Pharma Key Figures

(at previous day's close)
Market Cap.72.04m
Shares In Issue65.49m
Prev. Close109.50
PE Ratio- 
Dividend Yield-%
EPS - basic-36.17p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-35.02p
Return On Equity (ROE)-53.08%
Operating Margin-%
PEG Factor- 
EPS Growth Rate-15.15%
Dividends PS Growth Rate-%
Net Debt-9.21m
Gross Gearing13.01%
Quick Assets33.01m
Net Working Capital28.12m
Intangibles / Fixed Assets74.81%
Turnover PS-p
Pre-Tax Profit PS-43.42p
Retained Profit PS-37.09p
Cash PS24.51p
Net Cash PS16.61p
Net Tangible Asset Value PS *47.82p
Net Asset Value PS69.87p
Spread2.00 (1.80%) 

4d Pharma Balance Sheet

DDDD:Liabilities+EQDDDD:Assets

Share Price Performance

Sample Period HighLow
1 week114.0090.00
4 weeks114.0087.50
12 weeks131.0065.00
1 year147.5065.00

Share Price Chart (5 years)

4d Pharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week90.0020.0022.2290.000.20103.70
4 weeks100.509.509.4587.500.1694.32
12 weeks66.0044.0066.6765.000.6393.02
26 weeks97.0013.0013.4065.000.3292.82
1 year129.75-19.75-15.2265.000.1895.63
3 years675.00-565.00-83.7065.000.09135.94
5 years327.50-217.50-66.4165.000.07268.32

4d Pharma Key Management Ratios

4d Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 1.11 
Tobin's Q Ratio (excl. intangibles)1.42 
Dividend Yield-%
Market-to-Book Ratio1.57 
Price-to-Pre-Tax Profit PS-2.53 
Price-to-Retained Profit PS-2.97 
Price-to-Cash Flow PS-3.14 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS2.30 
Price-to-Cash PS4.49 
Net Working Capital PS42.93 
Price Pct to Working Capital PS2.56%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

4d Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio3.51%
Debt-to-Equity Ratio0.04 
Debt-to-Equity Ratio (excl. Intgbl)0.05 
Debt-to-Equity Market Value0.02 
Net Gearing-17.51%
Net Gearing (excl. Intangibles)-24.14%
Gross Gearing13.01%
Gross Gearing (excl. Intangibles)17.93%
Gearing Under 1 Year9.84%
Gearing Under 1 Year (excl. Intgbl)13.57%
Assets/Equity1.15 
Cash/Equity35.08 
(Liquidity Ratios)
Net Working Capital to Total Assets53.45%
Current Ratio6.43 
Quick Ratio (Acid Test)6.38 
Liquidity Ratio3.10 
Cash & Equiv/Current Assets48.21%
(Solvency Ratios)
Enterprise Value57.66m
CFO/Sales- 
CFO/Attributable Profit- 
CFO/Assets-0.44 
CFO/Debt-3.35 
Total Debt/Equity Market Value0.09 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.24 
Total Debt6.84m
Total Debt/Net Current Assets0.24%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs4 
Beta (60-Mnth)Beta (36-Mnth)
-0.8277-0.0920

4d Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-59.96%
Return On Assets (ROA)-37.27%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-53.08%
Return On Investment (ROI)-40.42%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debtors-to-Sales-%
Debt Collection Period-Days

4d Pharma Dividends

Sorry No Data Available

4d Pharma Fundamentals

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
turnover--------m
pre tax profit-10.06--11.71--23.99--28.44-m
attributable profit-7.55--10.25--19.39--24.29-m
retained profit-7.55--10.25--19.39--24.29-m
eps - basic (p)-12.62 -15.21 -31.41 -36.17 
eps - diluted (p)-12.62 -15.21 -31.41 -36.17 
dividends per share- - - - 

4d Pharma Balance Sheet

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
DDDD:Liabilities+EQDDDD:AssetsDDDD:Liabilities+EQDDDD:AssetsDDDD:Liabilities+EQDDDD:AssetsDDDD:Liabilities+EQDDDD:Assets
 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
ASSETS
fixed assets fixed assets1.121.14%3.864.14%5.216.70%4.879.25%m
intangibles intangibles6.176.34%14.3015.35%14.6718.88%14.4527.46%m
fixed investments fixed investments83.6685.91%40.1143.06%38.1349.05%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks0.030.03%0.240.26%0.250.33%0.290.55%m
debtors debtors4.644.76%5.996.43%7.609.78%16.9532.23%m
cash & securities cash & securities1.781.82%28.6630.77%11.8715.26%16.0530.52%m
TOTAL97.39100%93.16100%77.74100%52.61100%m
LIABILITIES
creditors - short creditors - short4.314.42%4.945.30%4.986.41%5.189.84%m
creditors - long creditors - long0.390.40%1.741.86%2.973.82%1.673.17%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL4.694.82%6.677.16%7.9510.23%6.8413.01%m
EQUITY
ord cap, reserves ord cap, reserves92.7095.18%86.4892.84%69.7989.77%45.7686.99%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL92.7095.18%86.4892.84%69.7989.77%45.7686.99%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

4d Pharma Cash Flow Statement

31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
Operating CF-9.07-13.53-17.19-22.94m
Pre-Financing CF-90.8226.88-16.784.20m
Retained CF-27.0526.88-16.804.19m

4d Pharma Brokers

Broker infomation is not available for this class of stock.
Your Recent History
LSE
DDDD
4d Pharma
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191208 00:05:33